Impact of 4 Months of Exercise Changes of Heart Health-related Epigenetic Markers in Healthy, Sedentary Individuals (miR-4-heart)
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT04791306 |
|
Recruitment Status :
Recruiting
First Posted : March 10, 2021
Last Update Posted : July 22, 2021
|
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
| Condition or disease | Intervention/treatment | Phase |
|---|---|---|
| Sedentary Behavior | Other: supervised exercise training Other: home-based exercise training | Not Applicable |
Exercise induced changes in heat health related miRNA expression pattern are analyzed in plasma samples collected at rest and immediately after the completion of an all-out ergo spirometry test, conducted during the baseline examination. Additionally participants will perform a pulse wave analysis to evaluate their arterial stiffness, a bioimpedanzanalysis to evaluate their body composition, blood lipids will be measured as well as their exercise capacity.
After the baseline examination, all participants will perform once per week a supervised endurance and strength training at our facility. In addition, the participants will be provided with a digital application for planning and documentation of their home based physical activity. Together with an expert, they plan their weekly physical activities so that they reach 150 min of physical activity each week over a period of 4 months.
After this training/exercise intervention all participants will perform all measurements from the baseline examination again.
| Study Type : | Interventional (Clinical Trial) |
| Estimated Enrollment : | 39 participants |
| Allocation: | N/A |
| Intervention Model: | Single Group Assignment |
| Masking: | None (Open Label) |
| Primary Purpose: | Basic Science |
| Official Title: | Impact of a 4 Months Training Intervention on Exercise-induced Changes of Heart Health-related Epigenetic Markers in Healthy, Sedentary Individuals |
| Actual Study Start Date : | July 1, 2021 |
| Estimated Primary Completion Date : | March 31, 2023 |
| Estimated Study Completion Date : | March 31, 2025 |
| Arm | Intervention/treatment |
|---|---|
|
Experimental: Exercise Training
All participants should increase their physical activity level to at least 150 min per week, guided with once a week supervised in-house training as well as an application for planning and documentation for home-based physical activity
|
Other: supervised exercise training
Participates perform once a week for 4 months an in-house supervised endurance and strength training. Other: home-based exercise training Participants are provided with an application for planning and documentation of their physical activity, together with an expert participants plan their physical activities for their home-based training to reach at least 150 min physical activity per week. |
- miRNA expression response to acute all-out exercise (ergometry) [ Time Frame: Baseline ]expression change of miRNA due to all-out ergometry at baseline
- Change from baseline miRNA expression at 4 months [ Time Frame: after 4 months of exercise intervention ]4 months of exercise intervention in healthy previously sedentary participants leads to exercise-induced changes in the cardio protective miRNA expression profiles
- Change from baseline in miRNA expression response to acute all-out exercise (ergometry) at 4 months [ Time Frame: after 4 months of exercise intervention ]4 months of exercise intervention in healthy previously sedentary participants leads to a change in the acute exercise response (all-out ergometry).
- Heart rate [ Time Frame: Before and after 4 months of exercise intervention ]Heart rate will be measured by graded exercise testing on cycle ergometer.
- blood lipides [ Time Frame: Before and after 4 months of exercise intervention ]blood lipides will be measured before and after intervention
- arterial stiffness [ Time Frame: Before and after 4 months of exercise intervention ]arterial stiffness will be measured before and after intervention
- body composition [ Time Frame: Before and after 4 months of exercise intervention ]body composition will be measured before and after intervention
- exercise capacity [ Time Frame: Before and after 4 months of exercise intervention ]exercise capacity will be measured by graded exercise testing on cycle ergometer.
- body weight [ Time Frame: Before and after 4 months of exercise intervention ]body weight will be measured before and after intervention
- digital application [ Time Frame: 4 months of exercise intervention ]user feedback and user experience will be evaluated after the intervention
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the contacts provided below. For general information, Learn About Clinical Studies.
| Ages Eligible for Study: | 18 Years and older (Adult, Older Adult) |
| Sexes Eligible for Study: | All |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- <150min physical activity per week
- >18 years of age
- male and female
- signed inform consents
Exclusion Criteria:
- acute or chronic cardiovascular diseases, exempt arterial hypertension (systolic blood pressure >140 mmHg and diastolic blood pressure >90 mmHg in untreated and medical treated subjects)
- acute or chronic lung disease
- Alcohol (>30g/day) or drug abuse
- Adipositas grad 2 (BMI >35kg/m²)
- Orthopedic limitations to exercise capacity
- pregnant or breast feeding women
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04791306
| Contact: Prof. Josef Niebauer, MD PhD MBA | +43(0) 5 7255 ext 23200 | j.niebauer@salk.at | |
| Contact: Barbara Mayr, PhD | +43(0) 5 7255 ext 57080 | ba.mayr@salk.at |
| Austria | |
| Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University | Recruiting |
| Salzburg, Austria, 5020 | |
| Contact: Prof. Josef Niebauer, MD, PhD, MBA 00436624482 ext 4270 j.niebauer@salk.at | |
| Contact: Barbara Mayr, PhD +43(0) 5 7255 ext 57080 ba.mayr@salk.at | |
| Principal Investigator: | Prof. Josef Niebauer, MD PhD MBA | Department of Sports Medicine, Prevention and Rehabilitation Paracelsus Medical University |
| Responsible Party: | Prof. Josef Niebauer M.D., Ph.D., MBA, Prim. Univ.Prof.Dr.Dr. Josef Niebauer, MBA, Paracelsus Medical University |
| ClinicalTrials.gov Identifier: | NCT04791306 |
| Other Study ID Numbers: |
UISM-13 |
| First Posted: | March 10, 2021 Key Record Dates |
| Last Update Posted: | July 22, 2021 |
| Last Verified: | July 2021 |
| Studies a U.S. FDA-regulated Drug Product: | No |
| Studies a U.S. FDA-regulated Device Product: | No |

